Table 1.
Patient Characteristic of all screened patients (A) and those treated in clinical trial (B).
| A. Screened Patient Characteristic | Number |
|---|---|
| Age | |
| Range | 42–81 |
| Median | 65 |
| Sex | |
| Male | 39 |
| Female | 41 |
| Race | |
| White | 74 |
| African American | 3 |
| Asian | 2 |
| Hispanic | 1 |
| Stage at Diagnosis | |
| Stage I | 1 |
| Stage II | 5 |
| Stage III | 8 |
| Stage IV | 63 |
| Performance Status (ECOG) | |
| 0 | 32 |
| 1 | 40 |
| 2 | 5 |
| B. Treated Patient Characteristic | Number |
| Age (Yrs.) | |
| Range | 55–78 |
| Median | 76 |
| Sex | |
| Male | 2 |
| Female | 2 |
| Race | |
| Caucasian | 4 |
| African American | 0 |
| Asian | 0 |
| Stage at Diagnosis | |
| Stage I | 0 |
| Stage II | 0 |
| Stage III | 3 |
| Stage IV | 1 |
| Performance Status (ECOG) | |
| 0 | 1 |
| 1 | 3 |
| Adjuvant Chemotherapy | 3 |
| Gemcitabine | 2 |
| 5-FU | 1 |
| Radiation | 3 |
| Surgery | 3 |
| Chemotherapy Regimens (Metastatic) | |
| Gemcitabine | 3 |